Metronomic Chemotherapy with Vinblastine, Cyclophosphamide, Methotrexate and Celecoxib in Progressive or Relapsed Childhood Cancers

被引：0
|
作者：
Aydin, B. [1 ]
Akyuz, C. [1 ]
Kalkan, N. [1 ]
Kurucu, N. [1 ]
Yalcin, B. [1 ]
Varan, A. [1 ]
Kutluk, T. [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Paediat Oncol, Ankara, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-0482
引用
收藏
页码：S193 / S193
页数：1
相关论文
共 50 条
  • [31] UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma
    Ulrich Herrlinger
    Johannes Rieger
    Joachim P. Steinbach
    Thomas Nägele
    Johannes Dichgans
    Michael Weller
    Journal of Neuro-Oncology, 2005, 71 : 295 - 299
  • [32] Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
    Herman Andres Perroud
    Carlos Maria Alasino
    Maria Jose Rico
    Leandro Ernesto Mainetti
    Francisco Queralt
    Stella Maris Pezzotto
    Viviana Rosa Rozados
    O. Graciela Scharovsky
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 365 - 374
  • [33] Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response
    Andres Perroud, Herman
    Maria Alasino, Carlos
    Jose Rico, Maria
    Ernesto Mainetti, Leandro
    Queralt, Francisco
    Maris Pezzotto, Stella
    Rosa Rozados, Viviana
    Graciela Scharovsky, O.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (02) : 365 - 374
  • [34] METRONOMIC CHEMOTHERAPY (MC) WITH ORAL URACIL/TEGAFUR (UFT), CYCLOPHOSPHAMIDE (CTX) AND CELECOXIB IN PRETREATED PATIENTS WITH ADVANCED GASTROINTESTINAL CANCERS: A PILOT CLINICAL STUDY WITH PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) EVALUATIONS
    Allegrini, G.
    Bocci, G.
    Barletta, M. T.
    Masi, G.
    Loupakis, F.
    Fioravanti, A.
    Desidero, T.
    Andreuccetti, M.
    Di Leo, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 165 - 165
  • [35] Metronomic methotrexate and cyclophosphamide after carboplatin included adjuvant chemotherapy in triple negative breast cancer: a phase III study
    Nasr, Khalid E.
    Osman, Mohammed A.
    Elkady, Mohammad S.
    Ellithy, Mahmoud A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (19)
  • [36] Efficacy of metronomic chemotherapy with oral cyclophosphamide and methotrexate in patients with non-Hodgkin lymphoma: a retrospective analysis at a single institution
    Jung, Joo Young
    Jang, Geundoo
    Song, Hunho
    Kim, Hyeong Su
    Choi, Dae Ro
    Kwon, Jung Hye
    Kim, Ho Young
    Han, Boram
    Kim, Jung Han
    Kim, Hyo Jung
    Zang, Dae Young
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3893 - 3900
  • [37] Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real-world data analyses and experience of one center
    Lu Qianyi
    Lee Kaping
    Xu Fei
    Xia Wen
    Zheng Qiufan
    Hong Ruoxi
    Jiang Kuikui
    Zhai Qinglian
    Li Yuan
    Shi Yanxia
    Yuan Zhongyu
    Wang Shusen
    CANCER COMMUNICATIONS, 2020, 40 (05) : 222 - 233
  • [38] Metronomic methotrexate and cyclophosphamide after carboplatin included adjuvant chemotherapy in triple-negative breast cancer: A phase III study
    El Kady, Mohammad Sabry
    El Nasr, Khalid
    Osman, Mohammed A. Moneam
    Ellithy, Mahmoud
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] METRONOMIC CYCLOPHOSPHAMIDE AND METHOTREXATE CHEMOTHERAPY COMBINED WITH 1E10 ANTI-IDIOTYPE VACCINE IN METASTATIC BREAST CANCER
    Soriano Garcia, J. L.
    Batista, N.
    Santiesteban, E.
    Lima, M.
    Garcia, R.
    Lorenzo Luaces, P.
    Montejo, N.
    Aguirre, F.
    Macias, A.
    Vazquez, A. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 182 - 183
  • [40] Low-dose "metronomic chemotherapy" with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit
    Masci, G.
    Losurdo, A.
    Gandini, C.
    Garassino, I.
    di Tommaso, L.
    Torrisi, R.
    Zuradelli, M.
    Santoro, A.
    ECANCERMEDICALSCIENCE, 2012, 6
12345